Search Results
912 results found-
CSL Behring's HAEGARDA, for the prevention of Hereditary Angioedema attacks, was approved by the US Food and Drug Administration in June 2017.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
As 2023 comes to a close, leaders in patient advocacy shared accomplishments and highlights in CSL.com’s annual survey.
https://www.csl.com/we-are-csl/vita-original-stories/2023/a-year-of-progress-for-patients -
CSL Behring CSL Behring discovers, develops and delivers the broadest range of products in the industry for treating rare and serious diseases such as haemophilia, von Willebrand disease (vWD), primary and secondary immune deficiencies (PID/SID), chronic inflammatory demyelinating polyneuropathy (CIDP), hereditary angioedema (HAE) and inherited respiratory disease.
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
The pandemic changed the way patient communities connect, but it didn’t change their “I got your back” philosophy, according to advocates we surveyed.
https://www.csl.com/we-are-csl/vita-original-stories/2022/finding-community-in-2022 -
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
https://www.csl.com/ -
A new survey of more than 1,000 U.S. residents finds that few know how common rare diseases are, but 85% said it was important to research innovative new treatments.
https://www.csl.com/we-are-csl/vita-original-stories/2024/survey-how-much-do-us-residents-know-about-rare-diseases -
Pathogen expert Nathan Roth leads a team that takes a vigilant approach with the medicines patients rely on.
https://www.csl.com/we-are-csl/vita-original-stories/2019/pathogen-expert-nathan-roth -
Few Australians understand how common rare diseases are, but 89% said it was important to research innovative new treatments, according to a new survey of 1,000 Australian adults.
https://www.csl.com/we-are-csl/vita-original-stories/2024/survey-how-much-do-australians-know-about-rare-diseases -
The U.S. Hereditary Angioedema Association (HAEA) and HAE International (HAEi) offer fun, educational and empowering programming for kids and young adults with the rare genetic condition.
https://www.csl.com/we-are-csl/vita-original-stories/2023/hae-youth-programs-around-the-globe